tiprankstipranks
Trending News
More News >

Charlie CY Yang Profile - Bank of America Securities Analyst

11 Followers
tipranks
Charlie CY Yang

Charlie CY Yang
Bank of America Securities

Wall Street Analyst
#721 out of 12,128 Wall Street Analysts
#2,079 out of 44,301 experts

Success Rate

64%
14 out of 22 ratings made a profit

Average Return

+59.90%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Charlie CY Yang's trades since 2024 and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of 59.9% per rating.

Stock Rating Distribution

37Ratings
59.46% Buy
35.14% Hold
5.41% Sell
Distribution of Charlie CY Yang's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Amylyx Pharmaceuticals, Inc.
(AMLX)
Rating:Buy
Date:Apr 08, 2025 - Today
Return:+322.60%
The most profitable rating made by Charlie CY Yang

Charlie CY Yang's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Century Therapeutics
Aug 08, 2024
Buy
Reiterated
$6.00
(160.87% Upside)
1Ratings
0%
-71.80%
Pfizer
Oct 30, 2024
Hold
Reiterated
1Ratings
0.00%
AbbVie
Oct 30, 2024
Hold
Reiterated
$210.00
(0.80% Upside)
2Ratings
0.00%
Bristol-Myers Squibb
Nov 01, 2024
Hold
Assigned
$60.00
(1.06% Upside)
1Ratings
0.00%
Merck & Company
Nov 01, 2024
Buy
Assigned
$120.00
(4.82% Upside)
3Ratings
0%
-18.47%
Royalty Pharma
Nov 19, 2024
Buy
Reiterated
$39.00
(-14.83% Downside)
2Ratings
100%
+49.80%
Amgen
Nov 26, 2024
Hold
Reiterated
$335.00
(-4.69% Downside)
3Ratings
0.00%
Neumora Therapeutics, Inc.
Jan 03, 2025
Buy
Reiterated
$7.00
(165.15% Upside)
3Ratings
0%
-65.60%
TSBX
Turnstone Biologics Corp.
Feb 05, 2025
Hold
Assigned
3Ratings
100%
+0.80%
Apogee Therapeutics
Feb 12, 2025
Buy
Reiterated
$80.00
(19.81% Upside)
3Ratings
67%
+46.30%
List of latest recommendations made by Charlie CY Yang. Click to expand and see Charlie CY Yang's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Charlie CY Yang activity FAQ

What is the performance of Charlie CY Yang's recommendations?
The percentage of profitable recommendations made by Charlie CY Yang is 64%, and the average return per transaction is 59.90%.
    What stocks does Charlie CY Yang cover?
    Charlie CY Yang mostly covers AMLX ,IGMS ,APGE stocks.
      What was Charlie CY Yang's most profitable rating?
      Charlie CY Yang’s most profitable ratings was a buy on AMLX stock on Apr 08, 2025 - Today. The return on the trade was +322.60%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here